Treatment of Congenital Chylothorax in a Premature Infant using Octreotide.

Ahn,  Yoon Jin; Jeon,  You Hoon; Kim,  Sung Shin; Park,  Jae Ock; Kim,  Chang Hwi

Case Report

Journal of the Korean Society of Neonatology 2006;13(2):261-266.
Published online November 1, 2006.

Treatment of Congenital Chylothorax in a Premature Infant using Octreotide.

Yoon Jin Ahn, You Hoon Jeon, Sung Shin Kim, Jae Ock Park, Chang Hwi Kim

Department of Pediatrics, College of Medicine, Soonchunhyang University, Bucheon and Seoul Hospital, Korea. kimss@schbc.ac.kr

미숙아에서 Octreotide를 사용하여 치료한 선천성 유미흉 1례

^, ^, ^, ^,

Abstract

Chylothorax, defined as escape of chyle from the thoracic duct into the thoracic cavity, is the most common cause of pleural effusion during the neonatal period. The use of octreotide, a synthetic analogue of the somatostatin, for the treatment of congenital idiopathic chylothorax, has not been previously reported in Korea. We report here a case of idiopathic congenital chylothrax successfully treated with octreotide in a premature infant who showed no response to conservative therapies.

Key Words: Congenital; Chylothorax; Somatostatin; Octreotide; Prematurity